OnabotulinumtoxinA for Trigeminal Neuralgia Treatment OnabotulinumtoxinA, a Food and Drug Administration (FDA)approved treatment for chronic migraine, has been used off-label by neurologists as a safe alternative for the management of TN
doi: 10.1038/s41392-023-01569-3 Summary Keywords arginine metabolism, glutamine metabolism, immunometabolism, metabolic reprogramming, therapeutic targeting, tryptophan catabolism Citation Yin Y, Yan C, Pei X, Rao J, Wu L, Xue Y, Sun H and Sheng Y (2026) Amino acid metabolism modulates macrophage polarization: implications for autoimmune-related diseases
When Does Ozempic Face Typically Occur
GLP-1 medications create the caloric deficit by suppressing appetite and slowing gastric emptying